Predominant subtype of heart failure after acute myocardial infarction is heart failure with non-reduced ejection fraction.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
02 2021
Historique:
received: 10 03 2020
revised: 04 09 2020
accepted: 05 10 2020
pubmed: 10 12 2020
medline: 2 7 2021
entrez: 9 12 2020
Statut: ppublish

Résumé

Patients who survive acute myocardial infarction (AMI) are at risk of being rehospitalized owing to the occurrence of acute decompensated heart failure (HF). However, the clinical characteristics of HF after AMI, especially the frequency of each HF subtype, are unclear. We retrospectively studied 1055 patients with AMI. We excluded 257 patients, who were admitted >48 h after the onset of AMI, died during hospitalization or after discharge, and whose echocardiogram data at index hospitalization and follow-up data were missing. The remaining 798 patients (mean age: 66.5 ± 11.7 years) were investigated for a mean follow-up period of 4.9 years. All patients underwent emergency coronary angiography. The mean maximum creatine kinase levels were 2898 ± 2627 IU/L, and mean left ventricular ejection fraction (LVEF) was 58.9 ± 10.2%. Eighty-one patients (10.2%) were rehospitalized because of unexpected worsening of HF. Echocardiography data were available for 74 of the 81 patients during the acute phase of the second hospitalization, of which 30, 20, and 24 patients (41%, 27%, and 32%, respectively) were diagnosed as having HF with preserved LVEF (LVEF ≥ 50%), HF with mid-range LVEF (40% ≤ LVEF < 50%), and HF with reduced LVEF (LVEF < 40%), respectively. The ejection fraction during index hospitalization was 58.3 ± 9.7% in the HF with preserved LVEF group, 53.3 ± 10.2% in the HF with mid-range LVEF group, and 43.3 ± 10.5% in the HF with reduced LVEF group (P < 0.001). The predominant subtypes of HF after AMI were HF with mid-range ejection fraction and preserved ejection fraction, or HF with non-reduced ejection fraction.

Identifiants

pubmed: 33295115
doi: 10.1002/ehf2.13070
pmc: PMC7835561
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

317-325

Informations de copyright

© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Références

JAMA. 2011 Oct 19;306(15):1669-78
pubmed: 22009099
Lancet. 2015 Feb 28;385(9970):812-24
pubmed: 25467564
BMJ Open. 2018 Mar 3;8(3):e018331
pubmed: 29502083
ESC Heart Fail. 2019 Dec;6(6):1105-1127
pubmed: 31997538
JAMA. 2007 May 2;297(17):1892-900
pubmed: 17473299
ESC Heart Fail. 2019 Oct;6(5):1057-1067
pubmed: 31325235
Circ J. 2017 Mar 24;81(4):520-528
pubmed: 28154296
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
Heart. 2015 Sep;101(17):1413-21
pubmed: 25855798
J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):6A-13A
pubmed: 8376698
J Am Heart Assoc. 2013 Oct 08;2(5):e000172
pubmed: 24103569
N Engl J Med. 2006 Jul 20;355(3):251-9
pubmed: 16855265
Circ Heart Fail. 2016 Jun;9(6):
pubmed: 27266854
BMJ. 2012 Jan 25;344:e356
pubmed: 22279115
J Am Coll Cardiol. 2014 Apr 1;63(12):1123-1133
pubmed: 24491689
Circulation. 1979 Mar;59(3):607-9
pubmed: 761341
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Eur Heart J. 2012 Jul;33(14):1750-7
pubmed: 21821849
Circulation. 2012 Jul 3;126(1):65-75
pubmed: 22615345
ESC Heart Fail. 2021 Feb;8(1):317-325
pubmed: 33295115
N Engl J Med. 1997 Nov 6;337(19):1360-9
pubmed: 9358131

Auteurs

Daisuke Kamon (D)

Department of Cardiovascular Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Yu Sugawara (Y)

Department of Cardiovascular Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Tsunenari Soeda (T)

Department of Cardiovascular Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Akihiko Okamura (A)

Department of Cardiovascular Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Yasuki Nakada (Y)

Department of Cardiovascular Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Yukihiro Hashimoto (Y)

Department of Cardiovascular Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Tomoya Ueda (T)

Department of Cardiovascular Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Taku Nishida (T)

Department of Cardiovascular Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Kenji Onoue (K)

Department of Cardiovascular Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Satoshi Okayama (S)

Department of Cardiovascular Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Makoto Watanabe (M)

Department of Cardiovascular Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Rika Kawakami (R)

Department of Cardiovascular Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Yoshihiko Saito (Y)

Department of Cardiovascular Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH